April 3, 2025 - 07:44

A troubling trend has emerged among newly diagnosed type 2 diabetes patients, as nearly 40% are reported to stop their medication within the first year. Experts from UVA Health have highlighted this alarming statistic in a recent publication, emphasizing the potential health risks associated with such decisions.
Discontinuing prescribed diabetes medications can lead to serious complications, including increased blood sugar levels and a higher risk of cardiovascular diseases. The findings suggest that many patients may not fully understand the importance of their treatment regimen or may face barriers that prevent them from adhering to their prescribed medications.
Health professionals are urged to engage in more comprehensive discussions with their patients about the necessity of continuous treatment and the consequences of non-compliance. Strategies to improve patient education and support systems are essential to ensure that individuals diagnosed with type 2 diabetes remain committed to their health management plans. This shift could significantly enhance patient outcomes and reduce the long-term impact of the disease.
November 5, 2026 - 18:43
Acadia's Bed Ramp Strategy Shows Positive ResultsAcadia Healthcare reported impressive results for the third quarter, achieving total revenue of $895.3 million. This marks a 5.1 percent increase compared to the same quarter last year,...
November 4, 2026 - 18:41
Shelter-in-Place Order Rescinded After Incident Near Yale Health CenterAuthorities have lifted the shelter-in-place order that was issued following a shooting incident near the Yale Health Center. Fortunately, no injuries were reported, and university officials...
November 4, 2026 - 07:43
Political Changes Create Opportunities for Dividend StocksWashington has just handed investors a plot twist. A recent Democratic sweep of Congress, combined with new concerns about debt ceiling negotiations and the impact on Treasury yields, is shifting...
November 3, 2026 - 22:04
Study Finds Shorter Radiation Treatment Beneficial for Breast Cancer PatientsBruce Haffty, MD, associate Vice chancellor for Cancer Programs at Rutgers Cancer, recently discussed the findings of a significant study published in the Journal of Clinical Oncology. This...